HC Wainwright Initiates Agios Coverage at Buy, Sets $55 Target
HC Wainwright initiated coverage of Agios Pharmaceuticals at Buy with a $55 price target. The target implies 44.3% upside from the Oct. 28 close of $38.12.
HC Wainwright initiated coverage of Agios Pharmaceuticals at Buy with a $55 price target. The target implies 44.3% upside from the Oct. 28 close of $38.12.